The PD-1/PD-L1 immune checkpoint axis, where PD-1 is expressed on tumor-infiltrating immune cells and PD-L1 on tumor cells, plays a critical role in suppressing adaptive antitumor immunity by enabling tumor immune escape [186]. This evidence concerns the gene PDCD1 and neoplasm.